v3.25.2
Share-based Issuances
6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Share-based Issuances

Note 6 – Share-based Issuances

 

Stock Options

 

The fair value of each option award is estimated on the date of grant using a Black Scholes option valuation model that uses the assumptions noted in the following table. Because Black Scholes option valuation models incorporate ranges of assumptions for inputs, these ranges are disclosed. Expected volatilities and based on implied volatilities from traded options on the Company’s stock, historical volatility of the Company’s stock, and other factors. The expected term of options granted is derived from the output of the valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

  

The following table presents the activity for stock options outstanding:

        
   Options   Weighted Average Exercise Price 
Outstanding - December 31, 2024   34,341   $123.88 
Granted        
Forfeited/canceled        
Exercised        
Outstanding – June 30, 2025   34,341   $123.88 

 

         
   Options   Weighted Average Exercise Price 
Outstanding - December 31, 2023   4,994   $812.43 
Granted        
Forfeited/canceled   (50)   1,011.16 
Exercised        
Outstanding – June 30, 2024   4,944   $810.56 

 

The following table presents the composition of options outstanding and exercisable:

                    
   Options Outstanding**   Options Exercisable** 
Exercise Prices  Number   Price   Life*   Number   Price* 
$8.67   29,413   $8.67    9.51    29,413   $8.67 
$1,230.63   131   $1,230.63    2.36    131   $1,230.63 
$1,808.79   411   $1,808.79    3.98    411   $1,808.79 
$1,185.75   1,822   $1,185.75    5.48    1,822   $1,185.75 
$760.75   428   $760.75    6.18    428   $760.75 
$514.25   917   $514.25    7.20    917   $514.25 
$168.30   118   $168.30    7.94    118   $168.30 
$106.25   1,101   $106.25    8.46    1,101   $106.25 
Total – June 30, 2025   34,341              34,341      

 

* Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
** The Company’s options summarized above have been retroactively restated for the effect of the 1-for-17 reverse stock split.

  

Restricted Stock Units

 

The following table presents the activity for restricted stock units outstanding:

        
  

Restricted Stock

Units

  

Weighted Average Grant Date

Fair Value

 
Outstanding - December 31, 2024   309   $960.84 
Granted        
Forfeited/canceled   (29)   527.00 
Vested/issued   (280)   1,006.64 
Outstanding – June 30, 2025      $ 

 

  

Restricted Stock

Units

  

Weighted Average Grant Date

Fair Value

 
Outstanding - December 31, 2023   676   $1,009.12 
Granted        
Forfeited/canceled        
Vested/issued        
Outstanding – June 30, 2024   676   $1,009.12 

 

The Company recognized share-based compensation expense related to stock options and restricted stock units of $21,158 and $132,488 for the three months ended June 30, 2025 and 2024, respectively and $98,064 and $305,777 for the six months ended June 30, 2025 and 2024. The remaining unvested share-based compensation expense of $83,918 is expected to be recognized over the next 30 months.